Assignee
GENENTECH INC
US·2,896 granted patents·2,780 pending applications·141,475 citations·filing 1979–2025
Top patents by PatentIndex Score
5,676 records- 0199US7862817B2Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodiesGENENTECH INC·Filed 2005·Granted Jan 4, 2011·126 cites·23 claims
- 0299US7695936B2Knobs and holes heteromeric polypeptidesGENENTECH INC·Filed 2006·Granted Apr 13, 2010·817 cites·73 claims
- 0399US7642228B2Method for making heteromultimeric polypeptidesGENENTECH INC·Filed 2001·Granted Jan 5, 2010·404 cites·40 claims
- 0499US7537931B2Humanized anti-ERBB2 antibodies and treatment with anti-ERBB2 antibodiesGENENTECH INC·Filed 2006·Granted May 26, 2009·83 cites·24 claims
- 0599US7501122B2Treatment with anti-ErbB2 antibody combinationsGENENTECH INC·Filed 2005·Granted Mar 10, 2009·76 cites·9 claims
- 0699US7498030B2Treatment with anti-ErbB2 antibodies and anti-hormonal compoundsGENENTECH INC·Filed 2005·Granted Mar 3, 2009·69 cites·14 claims
- 0799US7485302B2Treatment with anti-ErbB2 antibodies and chemotherapeutic agentsGENENTECH INC·Filed 2006·Granted Feb 3, 2009·109 cites·30 claims
- 0899US7371826B2Polypeptide variants with altered effector functionGENENTECH INC·Filed 2006·Granted May 13, 2008·1.1k cites·7 claims
- 0999US7365166B2Anti-VEGF antibodiesGENENTECH INC·Filed 2006·Granted Apr 29, 2008·90 cites·7 claims
- 1099US7335742B2Polypeptide variants with altered effector functionGENENTECH INC·Filed 2006·Granted Feb 26, 2008·167 cites·10 claims
- 1199US7332581B2Polypeptide variants with altered effector functionGENENTECH INC·Filed 2005·Granted Feb 19, 2008·1.2k cites·19 claims
- 1299US7183387B1Polypeptide variants with altered effector functionGENENTECH INC·Filed 2000·Granted Feb 27, 2007·223 cites·7 claims
- 1399US7169901B2Anti-VEGF antibodiesGENENTECH INC·Filed 2002·Granted Jan 30, 2007·160 cites·12 claims
- 1499US7122637B2Polypeptide variants with altered effector functionGENENTECH INC·Filed 2004·Granted Oct 17, 2006·188 cites·7 claims
- 1599US7060269B1Anti-VEGF antibodiesGENENTECH INC·Filed 2000·Granted Jun 13, 2006·342 cites·2 claims
- 1699US6998253B1Altered polypeptides with increased half-lifeGENENTECH INC·Filed 2000·Granted Feb 14, 2006·250 cites·11 claims
- 1799US6949245B1Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodiesGENENTECH INC·Filed 2000·Granted Sep 27, 2005·317 cites·24 claims
- 1899US6884879B1Anti-VEGF antibodiesGENENTECH INC·Filed 1997·Granted Apr 26, 2005·623 cites·14 claims
- 1999US6800738B1Method for making humanized antibodiesGENENTECH INC·Filed 2000·Granted Oct 5, 2004·274 cites·13 claims
- 2099US6737056B1Polypeptide variants with altered effector functionGENENTECH INC·Filed 2000·Granted May 18, 2004·3.4k cites·33 claims
- 2199US6719971B1Method for making humanized antibodiesGENENTECH INC·Filed 2000·Granted Apr 13, 2004·393 cites·5 claims
- 2299US6639055B1Method for making humanized antibodiesGENENTECH INC·Filed 2000·Granted Oct 28, 2003·523 cites·3 claims
- 2399US6582959B2Antibodies to vascular endothelial cell growth factorGENENTECH INC·Filed 1997·Granted Jun 24, 2003·283 cites·4 claims
- 2499US6407213B1Method for making humanized antibodiesGENENTECH INC·Filed 1992·Granted Jun 18, 2002·2.2k cites·82 claims
- 2599US6399063B1Monoclonal antibodies directed to the HER2 receptorGENENTECH INC·Filed 1998·Granted Jun 4, 2002·282 cites·18 claims
- 2699US6387371B1Monoclonal antibodies directed to the HER2 receptorGENENTECH INC·Filed 1999·Granted May 14, 2002·272 cites·14 claims
- 2799US6165464AMonoclonal antibodies directed to the HER2 receptorGENENTECH INC·Filed 1998·Granted Dec 26, 2000·363 cites·11 claims
- 2899US6121022AAltered polypeptides with increased half-lifeGENENTECH INC·Filed 1995·Granted Sep 19, 2000·1.2k cites·23 claims
- 2999US6054297AHumanized antibodies and methods for making themGENENTECH INC·Filed 1995·Granted Apr 25, 2000·2.3k cites·30 claims
- 3099US5869046AAltered polypeptides with increased half-lifeGENENTECH INC·Filed 1995·Granted Feb 9, 1999·2.5k cites·7 claims
- 3199US5834250AMethod for identifying active domains and amino acid residues in polypeptides and hormone variantsGENENTECH INC·Filed 1997·Granted Nov 10, 1998·432 cites·31 claims
- 3299US5821337AImmunoglobulin variantsGENENTECH INC·Filed 1992·Granted Oct 13, 1998·4k cites·15 claims
- 3399US5821333AMethod for making heteromultimeric polypeptidesGENENTECH INC·Filed 1995·Granted Oct 13, 1998·681 cites·27 claims
- 3499US5807706AMethod for making heteromultimeric polypeptidesGENENTECH INC·Filed 1995·Granted Sep 15, 1998·587 cites·26 claims
- 3599US5772997AMonoclonal antibodies directed to the HER2 receptorGENENTECH INC·Filed 1995·Granted Jun 30, 1998·437 cites·13 claims
- 3699US5770195AMonoclonal antibodies directed to the her2 receptorGENENTECH INC·Filed 1995·Granted Jun 23, 1998·492 cites·36 claims
- 3799US5739277AAltered polypeptides with increased half-lifeGENENTECH INC·Filed 1995·Granted Apr 14, 1998·980 cites·3 claims
- 3899US5731168AMethod for making heteromultimeric polypeptidesGENENTECH INC·Filed 1995·Granted Mar 24, 1998·2.6k cites·41 claims
- 3999US5725856AMonoclonal antibodies directed to the HER2 receptorGENENTECH INC·Filed 1995·Granted Mar 10, 1998·516 cites·26 claims
- 4099US5720954AMonoclonal antibodies directed to the HER2 receptorGENENTECH INC·Filed 1995·Granted Feb 24, 1998·328 cites·35 claims
- 4199US5677171AMonoclonal antibodies directed to the HER2 receptorGENENTECH INC·Filed 1994·Granted Oct 14, 1997·924 cites·39 claims
- 4299US5648237AExpression of functional antibody fragmentsGENENTECH INC·Filed 1995·Granted Jul 15, 1997·1.5k cites·47 claims
- 4399US5428130AHybrid immunoglobulinsGENENTECH INC·Filed 1992·Granted Jun 27, 1995·861 cites·23 claims
- 4499US5364934APlasma carboxypeptidaseGENENTECH INC·Filed 1993·Granted Nov 15, 1994·367 cites·5 claims
- 4599US5225538ALymphocyte homing receptor/immunoglobulin fusion proteinsGENENTECH INC·Filed 1991·Granted Jul 6, 1993·592 cites·29 claims
- 4699US5175273ANucleic acid intercalating agentsGENENTECH INC·Filed 1988·Granted Dec 29, 1992·1.3k cites·19 claims
- 4799US5116964AHybrid immunoglobulinsGENENTECH INC·Filed 1989·Granted May 26, 1992·1.4k cites·8 claims
- 4898US8785626B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2013·Granted Jul 22, 2014·54 cites·4 claims
- 4998US8030023B2Nucleic acid encoding DR5 antibodies and uses thereofGENENTECH INC·Filed 2006·Granted Oct 4, 2011·56 cites·8 claims
- 5098US7799900B2Immunoglobulin variants and uses thereofGENENTECH INC·Filed 2005·Granted Sep 21, 2010·103 cites·19 claims
Showing the top 50 of 5,676 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when GENENTECH INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →